Notice ID: 88bfddd9918141ee93a2b26dfdc11537Combined Synopsis/Solicitation
CDRH-2024-122027-Leakage Testing in Microfluidic Devices
Archived on June 9, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM UTC−04:00
- Posted
- May 3, 2024
- Notice type
- Combined Synopsis/Solicitation
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Place of performance
- Silver Spring, MD, 20993
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- FDA-RFQ-CDRH-2024-122027
- Notice ID
- 88bfddd9918141ee93a2b26dfdc11537
Description
FDA needs a leakage testing system that will be used for accurate detection of leaks in microfluidic devices under different operating conditions (i.e., flow rates and pressures) to understand the performance of existing testing platforms for assessing emerging device technologies. This system will benefit FDA regulatory science research and significantly reduce the test method development time by removing the need for FDA to design, develop, build, test, and validate a custom solution. See attached.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
FDA-RFQ-CDRH-2024-122027- Combined Synopsis
- Combined SynopsisCurrentMay 3, 2024
CDRH-2024-122027-Leakage Testing in Microfluidic Devices
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
FDA-RFQ-CDRH-2024-122027
Archive Date
Jun 9, 2024
Office Address
Beltsville, MD, 20705